SP

Shrey Prakash Shah

Active Director Partner DIN 09759920
DIN 09759920 First appointment Jan 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Jan 2019
Shareholding value - Across - companies

About Shrey Prakash Shah

Shrey Prakash Shah has 7 years in corporate governance. Holds Partner role. Formerly with 2 companies, such as Morbus Medicines Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09759920
Primary Designation Partner
First Appointment 24 Jan 2019
Oldest Company Age 7 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Morbus Medicines Private Limited U51909GJ2021PTC125976
Director 05 Sep 2022 2021 Active
Partner 24 Jan 2019 2019 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Savaria Buildcon Llp
Morbus Medicines Private Limited

Shareholding

Pro
Shareholding preview is available in the premium director profile.

Shares held, value and quarterly changes across all companies — with the full investment profile.

Unlock shareholding

Frequently Asked Questions about Shrey Prakash Shah

Shrey Prakash Shah has 7 years in corporate governance. Holds Partner role. Formerly with 2 companies, such as Morbus Medicines Private Limited. Engaged in General Business. Contributes to corporate operations.

Shrey Prakash Shah is associated with 0 companies as Partner.

Shrey Prakash Shah has expertise in General Business.

Shrey Prakash Shah has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available